Show simple item record

dc.contributor.authorSterne, J.A.C et al.
dc.date.accessioned2020-09-03T20:00:44Z
dc.date.available2020-09-03T20:00:44Z
dc.date.issued2020-08-24
dc.identifier.urihttps://doi.org/10.1186/s13063-020-04641-3en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12663/2171
dc.description.abstractPrimary objective: To estimate the effect of corticosteroids compared with usual care or placebo on mortality up to 28 days after randomization. Secondary objectives: To examine whether the effect of corticosteroids compared with usual care or placebo on mortality up to 28 days after randomization varies between subgroups related to treatment characteristics, disease severity at the time of randomization, patient characteristics, or risk of bias. To examine the effect of corticosteroids compared with usual care or placebo on serious adverse events.en_US
dc.languageEnglishen_US
dc.subjectCOVID-19en_US
dc.subjectRandomized Controlled Trialen_US
dc.subjectSystematic Reviewen_US
dc.subjectTranscortinen_US
dc.subjectDexamethasoneen_US
dc.subjectHydrocortisoneen_US
dc.subjectMethylprednisoloneen_US
dc.subjectMortalityen_US
dc.subjectMeta-Analysisen_US
dc.titleCorticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trialsen_US
eihealth.countryOthersen_US
eihealth.categoryInfection prevention and control, including health care workers protectionen_US
eihealth.categoryCandidate therapeutics RDen_US
eihealth.typePublished Articleen_US
eihealth.maincategorySave Lives / Salvar Vidasen_US
dc.relation.ispartofjournalTrialsen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record